Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Breast NeoplasmsNeoplasm Metastasis
Interventions
DRUG

Edotecarin

Trial Locations (19)

1090

Pfizer Investigational Site, Brussels

2610

Pfizer Investigational Site, Wilrijk

3000

Pfizer Investigational Site, Leuven

3050

Pfizer Investigational Site, Parkville

3165

Pfizer Investigational Site, East Bentleigh

7100

Pfizer Investigational Site, Haine-Saint-Paul

10021

Pfizer Investigational Site, New York

11030

Pfizer Investigational Site, Manhasset

21034

Pfizer Investigational Site, Dijon

31052

Pfizer Investigational Site, Toulouse

34059

Pfizer Investigational Site, Montpellier

37203

Pfizer Investigational Site, Nashville

44106

Pfizer Investigational Site, Cleveland

44121

Pfizer Investigational Site, Cleveland

44122

Pfizer Investigational Site, Orange

44145

Pfizer Investigational Site, Westlake

54511

Pfizer Investigational Site, Vandœuvre-lès-Nancy

75015

Pfizer Investigational Site, Paris

B-6000

Pfizer Investigational Site, Charleroi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY